Stock Report

All about this stock under one free report Last Updated: 05-Sep-2026

Stock Rating

See the stock’s health at a glance, before it's too late.

Wealth Insight New Issue

Serious stock insights. No fluff. No FOMO.

Recently Viewed

Clear All

ReShape Lifesciences (RSLS) Key Ratios

Stock Card factsheet share-fund-plan-icon

$3.92

up-down-arrow $-8.88 (-69.38%)

As on 14-Aug-2025 16:28EDT

Market cap

info icon

$9 Mln

Revenue (TTM)

info icon

$6 Mln

P/E Ratio

info icon

--

P/B Ratio

info icon

30.4

Div. Yield

info icon

0 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue 11.59 -36.79 -19.81 -19.09 -11.75
EBIT -15.23 -3.16 31.32 22.45 10.22
Net Profit -278.43 -64.89 50.13 24.64 14.04
EPS -147.45 90.18 92.50 25.97 14.61
Book Value -- -- -- -- --
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsTTMDec-24Dec-23
EBIT-Margin info -164.39-161.49-98.59-83.56-168.69
Net Margin info ---541.56-69.71----
Return on equity info -211.88-191.66---222.46-220.59
Return on Capital info -196.39-170.89---186.67-211.71
Return on Assets info -112.68-106.01-32.73-92.26-104.44
Debt to Equity (x) info ----0.00-3.820.04

Profitability

View Detailed Peer Comparison

ROCE

--

--

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
TTM
Dec-24
Dec-23
Dec-22
Dec-21
ReShape Lifesciences (RSLS)
--
-186.67
-211.71
-190.79
-180.61
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROE

--

--

Profit after tax / Average Net worth * 100

Company Name
TTM
Dec-24
Dec-23
Dec-22
Dec-21
ReShape Lifesciences (RSLS)
--
-222.46
-220.59
-192.58
-210.58
Peer Median
4.94
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROA

-32.73

Lower than Peers by 35.19

Profit after tax / Average Total assets * 100

Company Name
TTM
Dec-24
Dec-23
Dec-22
Dec-21
ReShape Lifesciences (RSLS)
-32.73
-92.26
-104.44
-141.33
-135.64
Peer Median
2.45
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Margin

-98.59

Lower than Peers by 107.06

Operating profit (EBIT) / Net Sales * 100

Company Name
TTM
Dec-24
Dec-23
Dec-22
Dec-21
ReShape Lifesciences (RSLS)
-98.59
-83.56
-168.69
-240.91
-204.04
Peer Median
8.47
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Margin

-69.71

Lower than Peers by 74.39

Net profit / Total Income (Net sales plus other income) * 100

Company Name
TTM
Dec-24
Dec-23
Dec-22
Dec-21
ReShape Lifesciences (RSLS)
-69.71
-89.06
-131.22
-411.16
-455.39
Peer Median
4.68
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Profit Margin

0.00

--

(Net profit + Depreciation) / Gross Sales * 100

Company Name
TTM
Dec-24
Dec-23
Dec-22
Dec-21
ReShape Lifesciences (RSLS)
0.00
--
--
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Growth

View Detailed Peer Comparison

Revenue Growth

-19.81

Lower than Peers by 28.30

Year on year growth in net sales

Company Name
TTM
Dec-24
Dec-23
Dec-22
Dec-21
ReShape Lifesciences (RSLS)
-19.81
-0.08
-0.23
-0.17
0.20
Peer Median
8.49
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Growth

31.32

Higher than Peers by 20.67

Year on year growth in operating profit (EBIT)

Company Name
TTM
Dec-24
Dec-23
Dec-22
Dec-21
ReShape Lifesciences (RSLS)
31.32
54.30
45.94
2.42
-122.76
Peer Median
10.65
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Profit Growth

50.13

Higher than Peers by 36.58

Year on year growth in profit after tax

Company Name
TTM
Dec-24
Dec-23
Dec-22
Dec-21
ReShape Lifesciences (RSLS)
50.13
37.38
75.36
25.38
-186.33
Peer Median
13.55
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EPS Growth

92.50

Higher than Peers by 71.99

Year on year growth in earnings per share

Company Name
TTM
Dec-24
Dec-23
Dec-22
Dec-21
ReShape Lifesciences (RSLS)
92.50
-7.67
0.68
-24.42
0.99
Peer Median
20.51
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Book Value Growth

-88.56

Lower than Peers by 95.57

Year on year growth in book value per share

Company Name
TTM
Dec-24
Dec-23
Dec-22
Dec-21
ReShape Lifesciences (RSLS)
-88.56
--
--
--
--
Peer Median
7.01
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Solvency

View Detailed Peer Comparison

Debt to Equity

--

--

Total debt / Net worth

Company Name
TTM
Dec-24
Dec-23
Dec-22
Dec-21
ReShape Lifesciences (RSLS)
--
-3.82
0.04
0.05
0.01
Peer Median
0.40
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Short term debt to equity ratio

0.02

--

(Short term borrowings / Net worth)

Company Name
TTM
Dec-24
Dec-23
Dec-22
Dec-21
ReShape Lifesciences (RSLS)
0.02
-3.66
0.02
0.05
0.01
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Current Ratio

2.77

Lower than Peers by 0.05

Current Assets / Current Liabilities and Provisions

Company Name
TTM
Dec-24
Dec-23
Dec-22
Dec-21
ReShape Lifesciences (RSLS)
2.77
0.92
2.73
1.32
3.98
Peer Median
2.83
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Quick Ratio

1.97

Lower than Peers by 0.07

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
TTM
Dec-24
Dec-23
Dec-22
Dec-21
ReShape Lifesciences (RSLS)
1.97
0.43
1.74
0.84
3.58
Peer Median
2.05
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Interest Coverage

-76.10

Lower than Peers by 81.06

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
TTM
Dec-24
Dec-23
Dec-22
Dec-21
ReShape Lifesciences (RSLS)
-76.10
--
-563.04
-239.63
-33.35
Peer Median
4.96
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Operating Efficiency

View Detailed Peer Comparison

Debtors to sales

12.01

Lower than Peers by 4.44

Debtors outstanding / Net Sales * 100

Company Name
TTM
Dec-24
Dec-23
Dec-22
Dec-21
ReShape Lifesciences (RSLS)
12.01
12.33
19.12
19.40
20.70
Peer Median
16.46
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Asset Turnover

0.47

Lower than Peers by 0.03

Sales / Average Total Assets

Company Name
TTM
Dec-24
Dec-23
Dec-22
Dec-21
ReShape Lifesciences (RSLS)
0.47
1.04
0.80
0.34
0.30
Peer Median
0.50
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Receivable days

--

--

Average Debtors / Sales * 365

Company Name
TTM
Dec-24
Dec-23
Dec-22
Dec-21
ReShape Lifesciences (RSLS)
--
60.36
80.79
81.16
72.98
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Inventory Days

--

--

Average Inventory / Sales * 365

Company Name
TTM
Dec-24
Dec-23
Dec-22
Dec-21
ReShape Lifesciences (RSLS)
--
384.01
428.96
272.17
182.45
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Payable days

--

--

Average Creditors / Cost of goods sold * 365

Company Name
TTM
Dec-24
Dec-23
Dec-22
Dec-21
ReShape Lifesciences (RSLS)
--
241.33
210.92
221.96
247.68
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Conversion Cycle

--

--

Receivable Days + Inventory Days - Payable Days

Company Name
TTM
Dec-24
Dec-23
Dec-22
Dec-21
ReShape Lifesciences (RSLS)
--
203.04
298.83
131.36
7.75
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Valuation

View Detailed Peer Comparison

Price / Earnings

--

--

Current share price divided by earning per share in the last twelve months

Company Name
TTM
Dec-24
Dec-23
Dec-22
Dec-21
ReShape Lifesciences (RSLS)
--
-0.02
-0.01
-0.08
-0.47
Peer Median
44.46
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Price / Book Value

30.42

Higher than Peers by 26.62

Current share price divided by book value per share in the latest financial year

Company Name
TTM
Dec-24
Dec-23
Dec-22
Dec-21
ReShape Lifesciences (RSLS)
30.42
-0.52
0.02
0.96
0.65
Peer Median
3.79
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Dividend Yield

--

--

Dividend per share in the past twelve months divided by current share price

Company Name
TTM
Dec-24
Dec-23
Dec-22
Dec-21
ReShape Lifesciences (RSLS)
--
--
--
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EV/EBITDA

-0.02

--

Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)

Company Name
TTM
Dec-24
Dec-23
Dec-22
Dec-21
ReShape Lifesciences (RSLS)
-0.02
-0.06
0.28
0.01
-0.25
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Market Cap

9

Lower than Peers by 531

Current Share price multiplied by latest total number of shares outstanding

Company Name
TTM
Dec-24
Dec-23
Dec-22
Dec-21
ReShape Lifesciences (RSLS)
9
--
--
--
--
Peer Median
540
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...